BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, April 20, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

July 8, 1997

View Archived Issues

AHP discloses agents useful for disorders of the dopaminergic system

Read More

SmithKline Beecham reports novel hemoregulatory compounds

Read More

Novartis discovers compounds with anti-PDE IV and other actions

Read More

Agents for BPH claimed by Merck & Co.

Read More

MS&D discloses selective 5-HT1D agonists

Read More

New antiinflammatory agents from Procter & Gamble

Read More

Kotobuki describes new compound with expectorant and antiinflammatory effects

Read More

Bioisosteres of sulfonylureas prepared by Belgian investigators

Read More

Sanwa Kagaku characterizes analogues of dynemicin A

Read More

Potent, selective and orally active ETA antagonist from Zeneca

Read More

Royce Laboratories' generic meperidine approved by FDA

Read More

New introduction for Ultiva

Read More

IVAX's generic estazolam cleared for marketing by FDA

Read More

Update on DepoTech's DepoCyt

Read More

Outcome in unstable angina improved with ReoPro

Read More

Navelbine introduced in the U.K.

Read More

First launch for antidepressant from Pharmacia & Upjohn

Read More

AIDS vaccine described by Takeda

Read More

Fixed-dose losartan/hydrochlorothiazide combination now available in U.K.

Read More

Dermatologic and Ophthalmic Drugs Advisory Committee meets July 14-15, 1997

Read More

Troponin I inhibits breast cancer growth in preclinical trial

Read More

AmBisome NDA to be discussed at Antiviral Drugs Advisory Committee meeting

Read More

FDA grants manufacturing approval for bulk ciclosporin

Read More

MRC initiates trial to improve survival of patients with resectable NSCLC

Read More

QLT PhotoTherapeutics files for Canadian approval of lung cancer treatment

Read More

Senetek seeks Danish approval of erectile dysfunction therapy

Read More

CarboMed licenses broad-spectrum anticancer agent to Zeneca

Read More

Virend superior to placebo for topical treatment of genital herpes in AIDS patients

Read More

Epix Medical and Dyax form alliance for the development of novel diagnostics

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 17, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • Novel caspase-2 inhibitor shows in vivo neuroprotective effects

    BioWorld Science
    Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing